Thanks Chicago and led for the excellent perspectives.

I won't harp any further about the structure or level of Don's compensation.

So I now understand Don gets paid by both Zenith and RVX.

I agree that Don has made incredible achievements with these companies. The odds of getting a drug to phase lll trials is extremely low and RVX has achieved the phase lll level with rvx-208.

I've never doubted Don's sincerity and honesty. I believe he is genuine and well intentioned and has the needs of RVX and Zenith in his heart and mind.

Thanks Led for the perspective re the expiring options.

Finally, I strongly believe that Don believes he has a blockbuster drug coming. There is no doubt of that in my mind. The post hoc research since July 2013 has yielded a remarkable set of reassuring findings regarding the multiple positive epigenetic effects that rvx-208 achieves. Don's recent interview delineated the effects clearly and BDAZ has expounded as well.

So if Don could get the communications cleaned up we may begin to see strong interest from investors.

Thanks for the posts. I continue to learn.

Regards

Toinv